378 related articles for article (PubMed ID: 28432017)
1. Dual-functional nanoparticles for precise drug delivery to Alzheimer's disease lesions: Targeting mechanisms, pharmacodynamics and safety.
Zheng X; Zhang C; Guo Q; Wan X; Shao X; Liu Q; Zhang Q
Int J Pharm; 2017 Jun; 525(1):237-248. PubMed ID: 28432017
[TBL] [Abstract][Full Text] [Related]
2. The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.
Zhang C; Zheng X; Wan X; Shao X; Liu Q; Zhang Z; Zhang Q
J Control Release; 2014 Oct; 192():317-24. PubMed ID: 25102404
[TBL] [Abstract][Full Text] [Related]
3. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
4. A hybrid siRNA delivery complex for enhanced brain penetration and precise amyloid plaque targeting in Alzheimer's disease mice.
Zheng X; Pang X; Yang P; Wan X; Wei Y; Guo Q; Zhang Q; Jiang X
Acta Biomater; 2017 Feb; 49():388-401. PubMed ID: 27845275
[TBL] [Abstract][Full Text] [Related]
5. Dual-functional nanoparticles targeting amyloid plaques in the brains of Alzheimer's disease mice.
Zhang C; Wan X; Zheng X; Shao X; Liu Q; Zhang Q; Qian Y
Biomaterials; 2014 Jan; 35(1):456-65. PubMed ID: 24099709
[TBL] [Abstract][Full Text] [Related]
6. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
[TBL] [Abstract][Full Text] [Related]
7. In vivo Evaluation and Alzheimer's Disease Treatment Outcome of siRNA Loaded Dual Targeting Drug Delivery System.
Zhang C; Gu Z; Shen L; Liu X; Lin H
Curr Pharm Biotechnol; 2019; 20(1):56-62. PubMed ID: 30727887
[TBL] [Abstract][Full Text] [Related]
8. [Effect of βsheet blocking peptide H102 on APP metabolic enzymes in hippocampal brain of double transgenic AD mice].
Jiang F; Sun FX; Xu SM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):299-303. PubMed ID: 29926633
[TBL] [Abstract][Full Text] [Related]
9. Dual-targeted magnetic mesoporous silica nanoparticles reduce brain amyloid-β burden via depolymerization and intestinal metabolism.
Liu N; Liang X; Yang C; Hu S; Luo Q; Luo H
Theranostics; 2022; 12(15):6646-6664. PubMed ID: 36185606
[No Abstract] [Full Text] [Related]
10. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
[TBL] [Abstract][Full Text] [Related]
11. Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice.
Liu Y; An S; Li J; Kuang Y; He X; Guo Y; Ma H; Zhang Y; Ji B; Jiang C
Biomaterials; 2016 Feb; 80():33-45. PubMed ID: 26706474
[TBL] [Abstract][Full Text] [Related]
12. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
13. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
[TBL] [Abstract][Full Text] [Related]
14. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
Zhu X; Wang S; Yu L; Jin J; Ye X; Liu Y; Xu Y
Aging Cell; 2017 Oct; 16(5):1073-1082. PubMed ID: 28771976
[TBL] [Abstract][Full Text] [Related]
15. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
16. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
[TBL] [Abstract][Full Text] [Related]
18. Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model.
Mi X; Du H; Guo X; Wu Y; Shen L; Luo Y; Wang D; Su Q; Xiang R; Yue S; Wu S; Gong J; Yang Z; Zhang Y; Tan X
Acta Biomater; 2022 Mar; 141():388-397. PubMed ID: 35045359
[TBL] [Abstract][Full Text] [Related]
19. Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells.
Sun T; Shi Q; Zhang Y; Power C; Hoesch C; Antonelli S; Schroeder MK; Caldarone BJ; Taudte N; Schenk M; Hettmann T; Schilling S; McDannold NJ; Lemere CA
J Control Release; 2021 Aug; 336():443-456. PubMed ID: 34186148
[TBL] [Abstract][Full Text] [Related]
20. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
